| Literature DB >> 33248546 |
Yuanyuan Wang1, Dianchun Wang1, Jiangshui Wang1, Kaixuan Li1, Chianning Heng1, Lei Jiang1, Chenhao Cai1, Xiuan Zhan2.
Abstract
In the present study, we evaluated the effects of various stocking densities on the tracheal barrier and plasma metabolic profiles of finishing broilers. We randomly assigned 1,440 Lingnan Yellow feathered broilers (age 22 d) to 5 different stocking density groups (8 m-2, 10 m-2, 12 m-2, 14 m-2, and 16 m-2). Each of these consisted of 3 replicates. The interleukin (IL)-1β and IL-10 concentrations were substantially higher in the 16 m-2 treatment group than they were in the 8 m-2 and 10 m-2 treatment groups (P < 0.05). Nevertheless, IL-4 did not significantly differ among the 5 treatments (P > 0.05). The tracheal mucosae of the birds in the 16 m-2 group (high stocking density, HSD) were considerably thicker than those for the birds in the 10 m-2 group (control, CSD). Relative to CSD, the claudin1 expression level was lower, and the muc2 and caspase3 expression levels were higher for HSD. Compared with CSD, 10 metabolites were significantly upregulated (P < 0.05), and 7 were significantly downregulated (P < 0.05) in HSD. Most of these putative diagnostic biomarkers were implicated in matter biosynthesis and energy metabolism. A metabolic pathway analysis revealed that the most relevant and critical biomarkers were pentose and glucuronate interconversions and the pentose phosphate pathway. Activation of the aforementioned pathways may partially counteract the adverse effects of the stress induced by high stocking density. This work helped improve our understanding of the harmful effects of high stocking density on the tracheal barrier and identified 2 metabolic pathways that might be associated with high stocking density-induced metabolic disorders in broilers.Entities:
Keywords: broiler; immunity; metabolomics; stocking density; tracheal barrier
Mesh:
Year: 2020 PMID: 33248546 PMCID: PMC7704944 DOI: 10.1016/j.psj.2020.09.026
Source DB: PubMed Journal: Poult Sci ISSN: 0032-5791 Impact factor: 3.352
Composition and nutrient level of the basal diet used in different phases of trial (% air-dry basis).
| Items | Starter (1–21 d) | Grower (22–42 d) | Finisher (43–60 d) |
|---|---|---|---|
| Ingredients, % | |||
| Corn | 58.00 | 35.50 | 33.50 |
| Sorghum | - | 16.00 | 17.00 |
| Barley | - | 10.00 | 13.00 |
| Soybean meal | 34.00 | 19.70 | 15.70 |
| Corn gluten meal | 2.00 | 5.80 | 5.30 |
| DDGS | 5.00 | 8.00 | |
| Lard | - | 4.00 | 3.70 |
| Soybean oil | 1.80 | - | - |
| NaCl | 0.40 | 0.30 | 0.30 |
| CaHPO4 | 1.30 | 1.00 | 1.00 |
| Limestone | 1.40 | 1.20 | 1.20 |
| Zeolite | 0.10 | 0.50 | 0.30 |
| Premix | 1.00 | 1.00 | 1.00 |
| Total | 100.00 | 100.00 | 100.00 |
| Nutrient levels | |||
| ME (MJ/kg) | 12.10 | 12.93 | 12.92 |
| CP | 22.94 | 21.63 | 19.63 |
| Lys | 1.25 | 1.03 | 0.90 |
| Met | 0.56 | 0.47 | 0.44 |
| Met + Cys | 0.90 | 0.78 | 0.74 |
| Calcium | 1.12 | 0.94 | 0.98 |
| Total phosphorus | 0.63 | 0.52 | 0.52 |
The Premix provides per kg of diet: Fe 75 mg, Cu 10 mg, Zn 95 mg, Mn 110 mg, I 0.35 mg, Se 0.30 mg, VA 9,600IU, VD3 2,700IU, VE36 mg, Vk3 3 mg, VB1 3 mg, VB2 10.5 mg, VB6 4.20 mg, VB12 0.03 mg, nicotinamide 60 mg, D-calcium pantothenate 18 mg, folic acid 1.5 mg, D-biotin 0.225 mg, choline, 500 mg.
ME is a calculated value; other nutrient levels are measured values.
DDGS is distillers dried grains with solubles.
Effects of stocking density on immune status in trachea of finishing broilers.
| Items | Stocking density (birds/m2) | SEM | |||||
|---|---|---|---|---|---|---|---|
| 8 | 10 | 12 | 14 | 16 | |||
| IL-1β (ng/g) | 0.098c | 0.099c | 0.120b | 0.124b | 0.149a | 0.004 | 0.000 |
| IL-4 (ng/g) | 0.469 | 0.484 | 0.454 | 0.479 | 0.460 | 0.063 | 0.744 |
| IL-10 (ng/g) | 0.298b | 0.296b | 0.303ab | 0.334ab | 0.347a | 0.008 | 0.102 |
a–cMeans within a row with not common superscripts significantly differ (P < 0.05).
Each value is the mean, n = 12.
Abbreviations: IL-1β, interleukin-1β; IL-4, interleukin-4; IL-10, interleukin-10.
Figure 1Effect of stocking density in trachea on finishing broilers. (A) Representative H&E-stained images; (B) Expression of claudin1, muc2, and caspase3 in trachea tissue were determined by Western blot. (C) Relative changes in the density of claudin1, muc2, and caspase3 were analyzed. Data presented as relative band intensity of claudin1, muc2, and caspase3 to β-actin. Values are means, with their SDs represented by vertical bars. (∗P < 0.05). Each value is the mean, n = 3.
Figure 2Total GC-TOF/MS ion flow about metabolites in the broilers' serum.
Figure 3(A) Principal component analysis (PCA) score plots, (B) orthogonal projections to latent structure-discriminant analysis (OPLS-DA) score plots (R2X = 0.0, R2Y = 0.089, Q2 = -0.25), and (C) permutation test of OPLS-DA from the LC-TOF/MS metabolite profiles of plasma for 16 birds/m2 vs. group 10 birds per m2. Blue circle: 16 birds per m2; green square: 10 birds per m2; Green circle: R2; blue square: Q2. The dash line represents the regression line for R2 and Q2.
Figure 4Volcano plots of metabolites in serum between 16 birds per m2 and 10 birds per m2 treatment groups. Each dot represents a metabolite. The larger dots indicate higher variable importance in the projection (VIP) values. The abscissa and ordinate represent the fold change and P-value of biomarkers, respectively. The increased and decreased (P < 0.05) biomarkers in the treatment group are represented by the red and blue dots, respectively, whereas the gray dots represent the unchanged (P > 0.05) metabolites between these 2 groups.
Serum differential metabolites between 16 birds/m2 and 10 birds/m2 treatment groups.
| Items | Mean | VIP | ||
|---|---|---|---|---|
| Stocking density (birds/m2) | ||||
| 16 | 10 | |||
| 6-Phosphogluconic Acid | 6.34E-04 | 2.05E-03 | 3.04 | 0.002 |
| Threonic Acid | 2.05E-02 | 1.52E-02 | 2.52 | 0.004 |
| Xylitol | 2.08E-02 | 1.73E-02 | 2.17 | 0.025 |
| Benzoic Acid | 1.62E-01 | 3.01E-01 | 2.08 | 0.021 |
| Heptadecanoic Acid | 6.64E-04 | 1.05E-03 | 2.01 | 0.041 |
| Threonine 2 | 1.78E-02 | 5.65E-03 | 1.99 | 0.050 |
| Halostachine 2 | 2.48E-03 | 1.75E-03 | 1.96 | 0.030 |
| Indole-3-Acetic Acid | 1.89E-04 | 5.37E-04 | 1.95 | 0.026 |
| Dioctyl Phthalate | 3.40E-03 | 5.18E-03 | 1.90 | 0.039 |
| Salicin | 1.21E-03 | 3.69E-03 | 1.84 | 0.000 |
| Uric Acid | 1.02E-03 | 2.35E-03 | 1.84 | 0.046 |
| 2,3-Dihydroxypyridine | 2.40E-03 | 1.53E-03 | 1.78 | 0.048 |
| Conduritol b Epoxide 2 | 4.85E-01 | 2.71E-01 | 1.59 | 0.015 |
| Glucoheptonic Acid 1 | 7.61E-03 | 2.69E-03 | 1.50 | 0.044 |
| 3-(1-Pyrazolyl)-L-Alanine | 3.25E-03 | 1.94E-03 | 1.35 | 0.005 |
| Cystine | 9.44E-03 | 5.56E-03 | 1.21 | 0.015 |
| 4-Acetamidobutyric Acid 2 | 2.61E-03 | 1.82E-03 | 1.14 | 0.049 |
Each value is the mean, n = 10.
Abbreviation: VIP, variable importance in the projection.
Pathway analysis for 16 birds/m2 and 10 birds/m2 treatment groups using MetaboAnalyst.
| Pathway name | Total | Hits | Raw p | Impact |
|---|---|---|---|---|
| Valine, leucine, and isoleucine biosynthesis | 10 | 1 | 0.067189 | 0 |
| Pentose and glucuronate interconversions | 17 | 1 | 0.1118 | 0.08333 |
| Pentose phosphate pathway | 20 | 1 | 0.13033 | 0.08333 |
| Cysteine and methionine metabolism | 27 | 1 | 0.17225 | 0 |
| Glycine, serine, and threonine metabolism | 33 | 1 | 0.20673 | 0.04786 |
| Tryptophan metabolism | 37 | 1 | 0.22901 | 0 |
| Arginine and proline metabolism | 38 | 1 | 0.23449 | 0 |
| Aminoacyl-tRNA biosynthesis | 44 | 1 | 0.26665 | 0 |
| Purine metabolism | 63 | 1 | 0.36073 | 0 |
Represents the total number of metabolites in the corresponding pathway.
Represents the actually matched number of metabolites.
Represents the P-values from enrichment analysis.
Represents the impact value calculated from pathway topology analysis. Each value is the mean, n = 10.
Figure 5Graphic summary of pathway analysis between 16 birds per m2and 10 birds per m2 treatment groups using MetaboAnalyst. The X-axis indicates the pathway impact, and Y-axis represents the pathway enrichment. Larger sizes and darker colors indicate higher pathway enrichment and higher pathway impact values, respectively.